Ticker Details
Spyre Therapeutics, Inc.
IPO Date:	April 4, 2016
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$6.43B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.91 | 3.30%
Avg Daily Range (30 D):	$2.09 | 2.92%
Avg Daily Range (90 D):	$1.41 | 2.78%

Institutional Daily Volume
Avg Daily Volume:	.12M
Avg Daily Volume (30 D):	1.13M
Avg Daily Volume (90 D):	.77M

Trade Size
Avg Trade Size (Sh.):	58
Avg Trade Size (Sh.) (30 D):	50
Avg Trade Size (Sh.) (90 D):	47

Institutional Trades
Total Institutional Trades:	1,319
Avg Institutional Trade:	$2.52M
Avg Institutional Trade (30 D):	$4.85M
Avg Institutional Trade (90 D):	$3.99M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.57M
Avg Closing Trade (30 D):	$12.73M
Avg Closing Trade (90 D):	$7.33M
Avg Closing Volume:	121.69K

News

Apr 15, 2026 @ 2:38 AM Spyre Therapeutics Announces Pricing of Upsized $4... Source: Not Specified

Apr 13, 2026 @ 8:46 PM Spyre Therapeutics Announces Proposed Public Offer... Source: Globe Newswire

Apr 13, 2026 @ 8:46 PM Spyre Therapeutics Announces Proposed Public Offer... Source: Not Specified

Apr 13, 2026 @ 11:00 AM Spyre Announces Potential Best-in-Class SPY001 Par... Source: Spyre Therapeutics, Inc.

Mar 19, 2026 @ 2:34 AM Signal or Noise: What VR Adviser's Spyre Theraputi... Source: Seena Hassouna

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS
Diluted EPS		$-.74
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-179.44M	$-69.01M	$-62.53M
Operating Income / Loss	$-201.64M	$-45.64M	$-57.17M
Cost of Revenue
Net Cash Flow	$48.69M	$11.46M	$20.82M
PE Ratio

Splits
Sep 08, 2023	1:25